Zealand Pharma A/s Stock
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | 1.670% | -10.890% | -7.644% | -41.586% | -35.996% | 127.093% | - |
| Saniona AB | -6.880% | 3.344% | 36.981% | 204.308% | 183.381% | 710.656% | -8.848% |
| Actinium Pharmaceuticals Inc. | 0.210% | 9.120% | 11.828% | 20.285% | 17.463% | -87.037% | -85.462% |
| NanoViricides Inc. | -4.630% | -6.364% | -16.260% | -25.899% | -31.333% | -11.550% | -64.236% |
News
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big
Cantor Boosts Rocket Lab Target to Street-High $35
Aerospace and defense corporation Rocket Lab USA (NASDAQ: RKLB) recently received a significant analyst boost when Cantor Fitzgerald increased its target price for the space company to a


